Cargando…
Selective serotonin reuptake inhibitors and venlafaxine in early pregnancy and risk of birth defects: population based cohort study and sibling design
Objective To assess whether use of specific selective serotonin reuptake inhibitors (SSRIs) or venlafaxine in early pregnancy is associated with an increased risk of birth defects, with emphasis on cardiovascular birth defects even when accounting for lifestyle or other familial confounding. Design...
Autores principales: | Furu, Kari, Kieler, Helle, Haglund, Bengt, Engeland, Anders, Selmer, Randi, Stephansson, Olof, Valdimarsdottir, Unnur Anna, Zoega, Helga, Artama, Miia, Gissler, Mika, Malm, Heli, Nørgaard, Mette |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group Ltd.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4410618/ https://www.ncbi.nlm.nih.gov/pubmed/25888213 http://dx.doi.org/10.1136/bmj.h1798 |
Ejemplares similares
-
Use of SSRI and SNRI Antidepressants during Pregnancy: A Population-Based Study from Denmark, Iceland, Norway and Sweden
por: Zoega, Helga, et al.
Publicado: (2015) -
Infant and childhood neurodevelopmental outcomes following prenatal exposure to selective serotonin reuptake inhibitors: overview and design of a Finnish Register-Based Study (FinESSI)
por: Malm, Heli, et al.
Publicado: (2012) -
Selective serotonin reuptake inhibitors and venlafaxine in early pregnancy and risk of birth defects: population based cohort study and sibling design
Publicado: (2015) -
Selective serotonin reuptake inhibitors and venlafaxine in pregnancy: Changes in drug disposition
por: Westin, Andreas Austgulen, et al.
Publicado: (2017) -
Correction: Selective serotonin reuptake inhibitors and venlafaxine in pregnancy: Changes in drug disposition
por: Westin, Andreas Austgulen, et al.
Publicado: (2018)